[{"Assets_0_Q1_USD":"8893201000.0","CIK":"875320","CommonStockSharesIssued_0_Q1_shares":"259079000.0","CommonStockSharesOutstanding_0_Q1_shares":"259079000.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"2.32","EarningsPerShareDiluted_1_Q1_USD":"2.29","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"72193451271.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"815698000.0","NetIncomeLoss_1_Q1_USD":"602753000.0","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","RevenuesConverted_1_Q1_USD":"1515107000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":"6461654000.0","Ticker":"VRTX","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"263515000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"259815000.0","filed":"20200501","footnote":null,"form":"10-Q","fp":"Q1","fy":"2020.0","name":"VERTEX PHARMACEUTICALS INC \/ MA","period":"20200331","qtrs":"0","uom":"USD"}]